SCHEMBL523267

SCHEMBL523267

CO[C@H]1C[C@H](n2cc(C)c(=O)[nH]c2=O)O[C@@H]1CO

nearest known ligand 0.72

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
RNASE1 P07998 1/20 0.69
TK1 P04183 6/20 0.65
LMNA P02545 2/20 0.63
TSHR P16473 2/20 0.63
ALB P02768 1/20 0.63
PKM P14618 1/20 0.63
BLM P54132 1/20 0.63
PMP22 Q01453 1/20 0.63
CYP2D6 P10635 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10431982 1.00 RNASE1 (0.69) RNASE1TK1LMNATSHRALB
SCHEMBL523268 1.00 RNASE1 (0.69) RNASE1TK1LMNATSHRALB
SCHEMBL16359947 1.00 RNASE1 (0.69) RNASE1TK1LMNATSHRALB
SCHEMBL19132672 1.00 RNASE1 (0.69) RNASE1TK1LMNATSHRALB
SCHEMBL12670320 1.00 RNASE1 (0.69) RNASE1TK1LMNATSHRALB
SCHEMBL25756080 1.00 RNASE1 (0.69) RNASE1TK1LMNATSHRALB
SCHEMBL8996152 0.91 RNASE1 (0.70) RNASE1TK1LMNATSHRALB
SCHEMBL22992460 0.91 RNASE1 (0.69) RNASE1TK1LMNATSHRALB
SCHEMBL4286458 0.91 RNASE1 (0.69) RNASE1TK1LMNATSHRALB
SCHEMBL27989242 0.91 RNASE1 (0.69) RNASE1TK1LMNATSHRALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 374 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4053780-B1 PERSONAL DATA DISTRIBUTION MANAGEMENT SYSTEM AND METHOD FOR SAME UNIV OSAKA (JP) 2026-05-27 EP claimed
US-12613247-B2 Labelling method to distinguish isobaric amino acids and amino acid combinations RAPID NOVOR INC. (CA) 2026-04-28 US claimed
EP-3865497-B1 METHOD FOR THE PREPARATION OF COLOURLESS CARBOHYDRATES OR COLOURLESS CARBOHYDRATE CRYSTALS SAVANNA INGREDIENTS GMBH & CO KG (DE) 2026-03-25 EP claimed
EP-3569368-B1 WORK MACHINE AND PICK-UP POSITION SELECTION METHOD FUJI CORP (JP) 2026-03-11 EP claimed
EP-4219366-B1 MEDIUM PROCESSING APPARATUS AND IMAGE FORMING SYSTEM INCORPORATING SAME RICOH CO LTD (JP) 2026-03-11 EP claimed
EP-4031972-B1 INDEXING AND REPLAYING TIME-TRAVEL TRACES USING DIFFGRAMS MICROSOFT TECHNOLOGY LICENSING LLC (US) 2026-02-25 EP claimed
EP-4521138-B1 METHOD AND SYSTEM OF SENSING THE BEST-CONNECTED FUTURE PATH FOR A MOBILE TELEROBOT TATA CONSULTANCY SERVICES LTD (IN) 2026-01-21 EP claimed
EP-3961580-B1 APPARATUS, METHOD, AND COMPUTER PROGRAM FOR OBJECT DETECTION TOYOTA MOTOR CO LTD (JP) 2026-01-07 EP claimed
EP-4099792-B1 METHOD AND DEVICE FOR TRANSMITTING AND RECEIVING SIGNAL IN WIRELESS COMMUNICATION SYSTEM LG ELECTRONICS INC (KR) 2025-12-24 EP claimed
EP-4272511-B1 MANAGING CONNECTIONS TO MULTIPLE CENTRALIZED UNITS GOOGLE LLC (US) 2025-12-03 EP claimed
EP-3564058-B1 MOTOR VEHICLE WITH PROJECTION DEVICE AND METHOD FOR OPERATING SUCH A PROJECTION DEVICE AUDI AG (DE) 2022-08-17 EP claimed
EP-3829259-B1 METHODS AND NODES FOR DECODING OF CONTENTION BASED UPLINK TRANSMISSIONS ERICSSON TELEFON AB L M (SE) 2022-07-20 EP claimed
EP-3406312-B1 INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING PROGRAM, AND INFORMATION PROCESSING METHOD NINTENDO CO LTD (JP) 2022-07-20 EP claimed
WO-2022144852-A1 SYSTEM AND METHOD FOR CLASSIFYING STRING DATA OF A PRIMARY ENTITY OF A DATA LAKE Alten (FR) 2022-07-07 WO claimed
EP-3466119-B1 SUBSCRIBER SELF-ACTIVATION DEVICE, PROGRAM, AND METHOD GIESECKE & DEVRIENT MOBILE SECURITY GMBH (DE) 2022-04-20 EP claimed
EP-3703811-B1 APPARATUS FOR PROGRAMMING A DEEP BRAIN STIMULATION SYSTEM AND A CLINICIAN PROGRAMMER DEVICE ADVANCED NEUROMODULATION SYSTEMS INC (US) 2022-04-13 EP claimed
EP-3808002-B1 CHANNEL HOPPING SEQUENCE GENERATION WITH VARIABLE CHANNEL WIDTH LANDIS & GYR INNOVATIONS INC (US) 2022-01-26 EP claimed
EP-0767842-A1 METHODS OF SCREENING FOR NUCLEOSIDE ANALOGS THAT ARE INCORPORATED BY HIV REVERSE TRANSCRIPTASE AND CAUSE INCORRECT BASE PAIRING DARWIN MOLECULAR CORPORATION (US) 1997-04-16 EP claimed
WO-1996000797-A1 METHODS OF SCREENING FOR NUCLEOSIDE ANALOGS THAT ARE INCORPORATED BY HIV REVERSE TRANSCRIPTASE AND CAUSE INCORRECT BASE PAIRING DARWIN MOLECULAR CORP (US) 1996-01-11 WO claimed
EP-0391411-A2 3'-Substituted methyl nucleosides as antiviral agents Bristol-Myers Squibb Company (US) 1990-10-10 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12613247-B2 Labelling method to distinguish isobaric amino acids and amino acid combinations DNPEP, ASNS, ANPEP RNASE1 82/4885TK1 946/4885LMNA 489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.